Renaissance Technologies
FLXN

Renaissance Technologies’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Renaissance Technologies’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,700
Closed -$100K – 3886
2020
Q1 		$100K Sell
12,700
-13,900
-52% -$209K ﹤0.01% 3229
2019
Q4 		$551K Sell
26,600
-15,800
-37% -$266K ﹤0.01% 2869
2019
Q3 		$581K Buy
+42,400
New +$503K ﹤0.01% 2814
2016
Q2 		– Sell
-124,500
Closed -$1.15M – 3577
2016
Q1 		$1.15M Buy
+124,500
New +$1.51M ﹤0.01% 2517
2015
Q3 		– Sell
-15,100
Closed -$331K – 3449
2015
Q2 		$331K Sell
15,100
-11,006
-42% -$222K ﹤0.01% 2846
2015
Q1 		$588K Buy
+26,106
New +$605K ﹤0.01% 2535

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return